Liv Johannessen, P.h.D.Syros Pharmaceuticals discusses Activity of SY-5609 an oral noncovalent potent and selective CDK7 inhibitor in preclinical models of colorectal cancerhttps://meetinglibrary.asco.org/record/188034/abstractASCO2020
Activity of SY-5609 an oral noncovalent potent and selective CDK7 inhibitor in preclinical models of colorectal cancer – Will this affect clinicians – Liv Johannessen P.h.D.Syros Pharmac…
